WealthShield Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History

WealthShield Partners’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$208	–	544
2026 Q1	$208	Buy	+2	New	+$211	﹤0.01%	605

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

WealthShield Partners's PJP Position: Q2 2026 in Review

WealthShield Partners sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 2 shares — an estimated $208 sold.

WealthShield Partners first reported a position in PJP in Q1 2026 and held it in 1 quarter. The position peaked at $208 in Q1 2026. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

WealthShield Partners reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
WealthShield Partners sold 2 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $208.
WealthShield Partners first reported a position in Invesco Pharmaceuticals ETF in Q1 2026 and held it in 1 quarter.
WealthShield Partners's Invesco Pharmaceuticals ETF position peaked at $208 in Q1 2026.
116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on WealthShield Partners's 13F filing for Q2 2026, filed 12 Aug 2026.